Seres therapeutics inc.

Major-Pharmaceuticals

MCRB


200 Sidney Street
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 0.9
    $ +0.06 7.41 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.63 - $0.58
  • YTD
  • 7.2%

  • Trading Volume
  • 5,922
  • Market Cap Full
  • $ 116.3M
  • Shares Outstanding
  • 129.3M
    Oct 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -24.3% 13.8% -27.6% 52% -5% -16% -14.5% 1.3% -44.4% 7.2%
Q2 9.4% 0.3% 24.5% -56% 4% 15.8% -51.8% -15.5% 1.4% -
Q3 -57.7% 42% -11.1% 35.7% 8% -70.8% 87.2% -50.3% -40.7% -
Q4 -19.5% -17.6% -37.7% -12.7% -13.5% 19.7% -12.8% -34.9% 17.2% -
J F M A M J J A S O N D
2025 7.2% - - - - - - - - - - -
2024 -19.3% 0.9% -31.8% -25.1% 73.2% -22.9% 73.3% -40.7% - - - -14.6%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%-72%2%-55%-22%596%-66%-33%-75%-40%7%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.50 0.63 -0.69 -0.59 -0.28 -0.39 -0.61 -0.57
Q2 0.70 0.69 -0.68 -0.24 -0.28 -0.53 -0.7 0.36
Q3 0.46 0.17 -0.54 -0.23 -0.36 0.72 -0.49 -0.37
Q4 0.63 0.71 -0.52 -0.18 -0.2 -0.52 -0.51 -
A 2.3 2.2 -2.4 -1.2 -1.1 -0.7 -2.3 -0.58

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 41 71.1 91.5 92 126.1
Jun 40.7 41.1 72.6 91.6 92.2 127.9
Sep 40.8 69.9 76.3 91.7 124.1 128.2
Dec 40.9 70 91.2 91.8 124.6 129.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 4.4 0.5 1.7 1
Total Asset Turnover - 0.4 0.1 0.3 0.2
Leverage
Debt Ratio 0.3 0.1 0.1 0.3 0.1
Debt – Equity Ratio 4.6 0.2 0.1 -0.5 -0.2
Interest Coverage -61.5 -32 -88 36 100
Equity multiplier 3.9 0.3 0.4 -0.4 -0.6